Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/vaccines13020144
PubMed Identifier: 40006691
Publication URI: http://europepmc.org/abstract/MED/40006691
Type: Journal Article/Review
Volume: 13
Parent Publication: Vaccines
Issue: 2
ISSN: 2076-393X